Outpatient antibiotic prescription rate and pattern in the private sector in India: Evidence from medical audit data


Autoři: Habib Hasan Farooqui aff001;  Aashna Mehta aff002;  Sakthivel Selvaraj aff002
Působiště autorů: Indian Institute of Public Health –Delhi, Public Health Foundation of India, Gurugram, Haryana, India aff001;  Health Economics, Financing and Policy, Public Health Foundation of India, Gurugram, Haryana, India aff002
Vyšlo v časopise: PLoS ONE 14(11)
Kategorie: Research Article
doi: 10.1371/journal.pone.0224848

Souhrn

The key objective of this research was to generate new evidence on outpatient antibiotic prescription rate and patterns in the private sector in India. We used 12-month period (May 2013 to April 2014) medical audit dataset from IQVIA (formerly IMS Health). We coded the diagnosis provided in the medical audit data to International Statistical Classification of Diseases and Related Health Problems (ICD-10) and the prescribed antibiotics for the diagnosis to Anatomic Therapeutic Chemical (ATC) classification of World Health Organization (ATC index-2016). We calculated and reported antibiotic prescription rate per 1,000 persons per year, by age groups, antibiotic class and disease conditions. Our main findings are—approximately 519 million antibiotic prescriptions were dispensed in the private sector, which translates into 412 prescriptions per 1,000 persons per year. Majority of the antibiotic prescriptions were dispensed for acute upper respiratory infections (J06) (20.4%); unspecified acute lower respiratory infection (J22) (12.8%); disorders of urinary system (N39) (6.0%); cough (R05) (4.7%); and acute nasopharyngitis (J00) (4.6%) and highest antibiotic prescription rates were observed in the age group 0–4 years. To conclude our study reports first ever country level estimates of antibiotic prescription by antibiotic classes, age groups, and ICD-10 mapped disease conditions.

Klíčová slova:

Age groups – Antibiotic resistance – Antibiotics – Global health – India – Outpatients – Pediatrics – Respiratory infections


Zdroje

1. Farooqui HH, Selvaraj S, Mehta A, Heymann DL. Community level antibiotic utilization in India and its comparison vis-a-vis European countries: Evidence from pharmaceutical sales data. PLoS One. 2018;13(10):e0204805. doi: 10.1371/journal.pone.0204805 30332450.

2. Klein EY, Van Boeckel TP, Martinez EM, Pant S, Gandra S, Levin SA, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A. 2018;115(15):E3463–E70. doi: 10.1073/pnas.1717295115 29581252.

3. Million Death Study C, Bassani DG, Kumar R, Awasthi S, Morris SK, Paul VK, et al. Causes of neonatal and child mortality in India: a nationally representative mortality survey. Lancet. 2010;376(9755):1853–60. doi: 10.1016/S0140-6736(10)61461-4 21075444.

4. Hersh AL, Jackson MA, Hicks LA, American Academy of Pediatrics Committee on Infectious D. Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics. Pediatrics. 2013;132(6):1146–54. doi: 10.1542/peds.2013-3260 24249823.

5. NCDC. National Treatment Guidelines for Antimicrobial Use in Infectious Diseases. New Delhi: National Center for Diease Control, 2016.

6. Pathak D, Pathak A, Marrone G, Diwan V, Lundborg CS. Adherence to treatment guidelines for acute diarrhoea in children up to 12 years in Ujjain, India—a cross-sectional prescription analysis. BMC Infect Dis. 2011;11:32. doi: 10.1186/1471-2334-11-32 21276243.

7. Kotwani A, Chaudhury RR, Holloway K. Antibiotic-prescribing practices of primary care prescribers for acute diarrhea in New Delhi, India. Value Health. 2012;15(1 Suppl):S116–9. doi: 10.1016/j.jval.2011.11.008 22265057.

8. Kotwani A, Holloway K. Antibiotic prescribing practice for acute, uncomplicated respiratory tract infections in primary care settings in New Delhi, India. Trop Med Int Health. 2014;19(7):761–8. doi: 10.1111/tmi.12327 24750565.

9. Durkin MJ, Jafarzadeh SR, Hsueh K, Sallah YH, Munshi KD, Henderson RR, et al. Outpatient Antibiotic Prescription Trends in the United States: A National Cohort Study. Infect Control Hosp Epidemiol. 2018;39(5):584–9. doi: 10.1017/ice.2018.26 29485018.

10. Ashworth M, Latinovic R, Charlton J, Cox K, Rowlands G, Gulliford M. Why has antibiotic prescribing for respiratory illness declined in primary care? A longitudinal study using the General Practice Research Database. J Public Health (Oxf). 2004;26(3):268–74. doi: 10.1093/pubmed/fdh160 15454595.

11. Huang N, Morlock L, Lee CH, Chen LS, Chou YJ. Antibiotic prescribing for children with nasopharyngitis (common colds), upper respiratory infections, and bronchitis who have health-professional parents. Pediatrics. 2005;116(4):826–32. doi: 10.1542/peds.2004-2800 16199689.

12. Chandy SJ, Thomas K, Mathai E, Antonisamy B, Holloway KA, Stalsby Lundborg C. Patterns of antibiotic use in the community and challenges of antibiotic surveillance in a lower-middle-income country setting: a repeated cross-sectional study in Vellore, South India. J Antimicrob Chemother. 2013;68(1):229–36. doi: 10.1093/jac/dks355 22945913.

13. Sharma M, Damlin A, Pathak A, Stalsby Lundborg C. Antibiotic Prescribing among Pediatric Inpatients with Potential Infections in Two Private Sector Hospitals in Central India. PLoS One. 2015;10(11):e0142317. doi: 10.1371/journal.pone.0142317 26540104.

14. Mackintosh M, Channon A, Karan A, Selvaraj S, Cavagnero E, Zhao H. What is the private sector? Understanding private provision in the health systems of low-income and middle-income countries. Lancet. 2016;388(10044):596–605. doi: 10.1016/S0140-6736(16)00342-1 27358253.

15. Reddy K. High Level Expert Group (HLEG) report on Universal Health Coverage (UHC) for India. New Delhi: Public Health Foundation of India, 2011.

16. Kshirsagar MJ, Langade D, Patil S, Patki PS. Prescribing patterns among medical practitioners in Pune, India. Bull World Health Organ. 1998;76(3):271–5. 9744247.

17. Phadke AR. The quality of prescribing in an Indian district. Natl Med J India. 1996;9(2):60–5. 8857039.

18. Shet A S S, Forsberg BC. Pharmacy-based dispensing of antimicrobial agents without prescription in India: appropriateness and cost burden in the private sector. Antimicrobial Resistance and Infection Control 2015;4(55).

19. IMS. IMS Heath.: IMS Health; 2016 [3/9/2016]. http://www.imshealth.com/en/about-us/our-company.

20. WHO. International Statistical Classification of Diseases and Related Health Problems 10th Revision 2016 [cited 2016]. http://apps.who.int/classifications/icd10/browse/2016/en.

21. WHOCC. WHO Collaborating Centre for Drug Statistics Methodology 2015 [cited 2016]. https://www.whocc.no/atc_ddd_index/.

22. GOI. Population Projection for India and States 2001–2026. New Delhi: OFFICE OF THE REGISTRAR GENERAL & CENSUS COMMISSIONER., 2006.

23. Clavenna A, Bonati M. Differences in antibiotic prescribing in paediatric outpatients. Arch Dis Child. 2011;96(6):590–5. doi: 10.1136/adc.2010.183541 21233078.

24. Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742–50. doi: 10.1016/S1473-3099(14)70780-7 25022435.

25. Gopalakrishnan S, Ganeshkumar P, Katta A. Assessment of prescribing practices among urban and rural general practitioners in Tamil Nadu. Indian J Pharmacol. 2013;45(3):252–7. doi: 10.4103/0253-7613.111931 23833368.

26. Kourlaba G, Kourkouni E, Spyridis N, Gerber JS, Kopsidas J, Mougkou K, et al. Antibiotic prescribing and expenditures in outpatient paediatrics in Greece, 2010–13. J Antimicrob Chemother. 2015;70(8):2405–8. doi: 10.1093/jac/dkv091 25881618.

27. Bianco A, Papadopoli R, Mascaro V, Pileggi C, Pavia M. Antibiotic prescriptions to adults with acute respiratory tract infections by Italian general practitioners. Infect Drug Resist. 2018;11:2199–205. Epub 2018/12/07. doi: 10.2147/IDR.S170349 30519057.

28. Davis ME, Liu TL, Taylor YJ, Davidson L, Schmid M, Yates T, et al. Exploring Patient Awareness and Perceptions of the Appropriate Use of Antibiotics: A Mixed-Methods Study. Antibiotics (Basel). 2017;6(4). Epub 2017/11/01. doi: 10.3390/antibiotics6040023 29088074.

29. Bert F, Gualano MR, Gili R, Scaioli G, Lovato E, Angelillo IF, et al. Knowledge and attitudes towards the use of antibiotics in the paediatric age group: a multicenter survey in Italy. Eur J Public Health. 2017;27(3):506–12. Epub 2016/11/12. doi: 10.1093/eurpub/ckw209 27836969.

30. Napolitano F, Izzo MT, Di Giuseppe G, Angelillo IF. Public knowledge, attitudes, and experience regarding the use of antibiotics in Italy. PLoS One. 2013;8(12):e84177. Epub 2014/01/01. doi: 10.1371/journal.pone.0084177 24376793.

31. Alsan M, Schoemaker L, Eggleston K, Kammili N, Kolli P, Bhattacharya J. Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis. Lancet Infect Dis. 2015;15(10):1203–10. doi: 10.1016/S1473-3099(15)00149-8 26164481.

32. Selvaraj S, Karan A. Deepening Health insecurity in india: evidence from National sample surveys since 1980s. Economic & Political Weekly 2009;(40):55–60.

33. Laxminarayan R, Chaudhury RR. Antibiotic Resistance in India: Drivers and Opportunities for Action. PLoS Med. 2016;13(3):e1001974. doi: 10.1371/journal.pmed.1001974 26934098.

34. Laxminarayan R, Matsoso P, Pant S, Brower C, Rottingen JA, Klugman K, et al. Access to effective antimicrobials: a worldwide challenge. Lancet. 2016;387(10014):168–75. doi: 10.1016/S0140-6736(15)00474-2 26603918.

35. Wattal C, Goel N, Oberoi JK, Raveendran R, Datta S, Prasad KJ. Surveillance of multidrug resistant organisms in tertiary care hospital in Delhi, India. J Assoc Physicians India. 2010;58 Suppl:32–6. 21563611.

36. Gandra S M N, Klein EY, Ashok A, Nerurkar V, Kumari M, et al. Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India. International Journal of Infectious Diseases. 2016;50:75–82. doi: 10.1016/j.ijid.2016.08.002 27522002

37. Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–98. doi: 10.1016/S1473-3099(13)70318-9 24252483.

38. Chandy SJ, Naik GS, Balaji V, Jeyaseelan V, Thomas K, Lundborg CS. High cost burden and health consequences of antibiotic resistance: the price to pay. J Infect Dev Ctries. 2014;8(9):1096–102. doi: 10.3855/jidc.4745 25212073.

39. Holstiege J, Schink T, Molokhia M, Mazzaglia G, Innocenti F, Oteri A, et al. Systemic antibiotic prescribing to paediatric outpatients in 5 European countries: a population-based cohort study. BMC Pediatr. 2014;14:174. doi: 10.1186/1471-2431-14-174 24997585.

40. Suda KJ, Hicks LA, Roberts RM, Hunkler RJ, Taylor TH. Trends and seasonal variation in outpatient antibiotic prescription rates in the United States, 2006 to 2010. Antimicrob Agents Chemother. 2014;58(5):2763–6. doi: 10.1128/AAC.02239-13 24590486.

41. Kotwani A, Wattal C, Katewa S, Joshi PC, Holloway K. Factors influencing primary care physicians to prescribe antibiotics in Delhi India. Fam Pract. 2010;27(6):684–90. doi: 10.1093/fampra/cmq059 20660529.

42. Holloway KA, Kotwani A, Batmanabane G, Puri M, Tisocki K. Antibiotic use in South East Asia and policies to promote appropriate use: reports from country situational analyses. BMJ. 2017;358:j2291. doi: 10.1136/bmj.j2291 28874360.

43. Walia K, Ohri VC. Strengthening surveillance key to addressing antimicrobial resistance. Indian J Med Microbiol. 2016;34(4):413–5. doi: 10.4103/0255-0857.195378 27934816.

44. CDSCO. Implementation of the Drugs and Cosmentics (Fourth Amendment) Rules. In: Organization CDSC, editor. New Delhi2014.

45. Will achieve full immunization coverage for all children by 2020 through a Catch-Up campaign [Internet]. New Delhi: Press Information Bureau 2014 [cited 3/9/2016]. http://pib.nic.in/newsite/PrintRelease.aspx?relid=114103


Článek vyšel v časopise

PLOS One


2019 Číslo 11